AKT1 and lung adenocarcinoma: TIMP-2 expression in lung adenocarcinomas was significantly associated with the alteration of driving proto-oncogene tyrosine-protein kinase (c-Src) and phosphatidylinositol 3-kinase/protein kinase B (PI3-kinase/AKT pathways) [177].